Oxazolidinone derivatives as adhesion receptor antagonists

Details Oxazolidinone derivatives as adhesion receptor antagonists Oxazolidinone derivatives as adhesion receptor antagonists

C - Chemistry, Metallurgy

07

D

C07D 263/24 (2006.01) A61K 31/42 (2006.01) A61K 31/445 (2006.01) A61K 31/495 (2006.01) A61P 19/10 (2006.01) C07D 413/02 (2006.01) C07D 413/06 (2006.01) C07D 413/10 (2006.01)

Patent

CA 2161857

Compounds of the formula I (see formula I) wherein R1, R2 and R3 have the meanings indicated, and also their physiologically acceptable salts, inhibit the binding of fibrinogen to the corresponding receptor and can be employed for the treatment of thromboses, osteoporoses, oncoses, apoplexy, cardiac infarct, ischaemias, inflammations, arteriosclerosis and osteolytic disorders.

Affiliated with

Also associated with

Rating

Oxazolidinone derivatives as adhesion receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxazolidinone derivatives as adhesion receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolidinone derivatives as adhesion receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1934449